Bibliographic Details
| Title: |
Recent Advances in the Therapeutic Efficacy of Artesunate. |
| Authors: |
Ruwizhi, Ngonidzashe1 (AUTHOR) 201515559@ufh.ac.za, Maseko, Rejoice Bethusile2 (AUTHOR) mreemaseko@gmail.com, Aderibigbe, Blessing Atim1 (AUTHOR) mreemaseko@gmail.com |
| Source: |
Pharmaceutics. Mar2022, Vol. 14 Issue 3, p504. 23p. |
| Subject Terms: |
*TREATMENT effectiveness, *ARTEMISININ derivatives, *ANTIMALARIALS, *ONCOGENIC viruses, *MALARIA, *LIPOSOMES, *SKIN diseases |
| Abstract: |
Artesunate, a semisynthetic artemisinin derivative, is well-known and used as the first-line drug for treating malaria. Apart from treating malaria, artesunate has also been found to have biological activity against a variety of cancers and viruses. It also exhibits antidiabetic, anti-inflammatory, anti-atherosclerosis, immunosuppressive activities, etc. During its administration, artesunate can be loaded in liposomes, alone or in combination with other therapeutic agents. Administration routes include intragastrical, intravenous, oral, and parenteral. The biological activity of artesunate is based on its ability to regulate some biological pathways. This manuscript reports a critical review of the recent advances in the therapeutic efficacy of artesunate. [ABSTRACT FROM AUTHOR] |
|
Copyright of Pharmaceutics is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
|
Full text is not displayed to guests. |
Login for full access.
|
